Tag: chemistry

  • Smart Bandage Monitors Severe Wound Healing

    1 October 2014. Researchers at Massachusetts General Hospital in Boston developed a paint-on covering for severe wounds that changes color to indicate the extent of healing taking place. The team from the lab of Conor Evans in Mass. General’s photomedicine center published its findings in today’s issue of Biomedical Optics Express, published by the Optical…

  • Safety Trial Underway for Addiction Drug Candidate

    23 September 2014. A clinical trial is underway testing the safety of a new therapy designed to treat addictions and compulsive behavior by Savant HWP, a drug development company in San Carlos, California. The study is testing the compound 18-methoxycoronaridine or 18-MC, conducted in South America by a Brazilian partner company identified as Hebron Farmaceutica…

  • Small Business Grant Funds Point-of-Care Sickle Cell Test

    22 September 2014. A Cambridge, Massachusetts diagnostics company received a Small Business Innovation Research (SBIR) grant to develop a simple point-of-care test for sickle cell disease, a genetic blood disorder affecting a large percentage of people of African origin. The $225,000 grant from National Institutes of Health’s SBIR program to Daktari Diagnostics will support development…

  • Calico Licenses Neurodegenerative Disease Compounds

    11 September 2014. California Life Company, better known as Calico, is licensing for development compounds shown to protect nerve cells in lab animals against degeneration and injury. Financial terms of the deal between Southwestern Medical Center and 2M Company in Dallas, with Calico, a one-year old company backed by Google, were not disclosed. A paper…

  • Ionic Liquids Shown to Combat Bacterial Biofilms

    27 August 2014. Researchers at Los Alamos National Lab in New Mexico developed a way to harness ionic liquids — salts in a liquid state — that in lab tests disrupt biofilms, antibiotic-resistant bacterial colonies, and boost treatments for skin infections. The team led by Los Alamos Lab’s David Fox and Samir Mitragotri at University…

  • Middle, Inner Ear Drug Developer Raises $100M in IPO

    13 August 2014. Otonomy Inc., a biopharmaceutical company in San Diego developing treatments for disorders of the middle and inner ear, raised $100 million in its initial public offering of stock. The company, trading on the NASDAQ under the symbol OTIC, priced its 6.25 million shares at $16.00. Otonomy was founded in 2008 by physicians…

  • Graphene Sensor Designed for Wearable Disease Detection

    7 August 2014. Engineers at University of Michigan in Ann Arbor designed a sensor from graphene that makes it possible to embed the technology into wearable devices for disease detection. The team from the labs of electrical engineering professor Zhaohui Zhong and biomedical engineering professor Sherman Fan published their results last month in the journal…

  • Engineered Protein Detoxes Pesticides, Chemical Weapons

    1 August 2014. Biochemists at New York University synthesized a protein that removes the toxic elements of chemicals found in pesticides and some chemical warfare agents. The team led by Jin Kim Montclare at NYU’s engineering school published its findings last week in the journal ChemBioChem (paid subscription required). The process, which includes use of…

  • Biochemical Signaling Chip Design Techniques Devised

    30 July 2014. Engineers at University of Maryland in College Park developed techniques for designing a chip device that controls biological functions of cells with electronic and biochemical signals. The team led by bioengineering professor William Bentley published its findings earlier this week in the journal Nature Nanotechnology (paid subscription required). Bentley and colleagues are…

  • U.S. Patent Awarded for Prodrug Cancer Imaging, Treatment

    30 July 2014. A new patent was awarded for a technology that detects and treats solid tumor cancers with a prodrug, a precursor compound activated inside the body — made by GenSpera Inc., a biotechnology company in San Antonio. U.S. patent number 8,772,226 was awarded on 8 July to inventors Samuel Denmeade and John Isaacs…